Jeba J, Backianathan S, Ishitha G, Singh A. Oral and gastrointestinal symptomatic metastases as initial presentation of lung cancer. BMJ Case Rep. 2016 Nov 18;2016:bcr2016217539. doi: 10.1136/bcr-2016-217539. PMID: 27864300; PMCID: PMC5129147. Link

Chandramohan A, Siddiqi UM, Mittal R, Eapen A, Jesudason MR, Ram TS, Singh A, Masih D. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020 Feb 25;7:100223. doi: 10.1016/j.ejro.2020.100223. PMID: 32140502; PMCID: PMC7044654.

Chandramohan A, Siddiqi UM, Mittal R, Eapen A, Jesudason MR, Ram TS, Singh A, Masih D. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020 Feb 25;7:100223. doi: 10.1016/j.ejro.2020.100223. PMID: 32140502; PMCID: PMC7044654. Link

Joel A, Mathew N, Andugala SS, Daniel S, Gnanamuthu BR, John AO, Georgy JT, Chacko RT, Irodi A, Yadav B, John S, Singh A. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting. Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. PMID: 33777179; PMCID: PMC7987494. Link

Joel A, Georgy JT, Thumaty DB, John AO, Chacko RT, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Jacob PM, Sebastian P, Backianathan S, Singh A. Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India. Ecancermedicalscience. 2021 Mar 19;15:1207. doi: 10.3332/ecancer.2021.1207. PMID: 33912232; PMCID: PMC8057782.

Bakshi G, Tongaonkar H, Addla S, Menon S, Pradhan A, Kumar A, Bapat A, Gore A, Joshi A, Raja A, Bradoo A, Ramesh A, Kumar A, Agrawal A, Ambekar A, Joshi A, Singh A, Singh BP, Dabkara D, Khadakban D, Gautam G, Prakash G, Pahwa HS, Goel HK, Kulkarni J, Mishra JJ, Patel K, Pal M, Chibber PJ, Tiwari P, Naik R, Raghunath SK, Krishnatry R, Shimpi R, Sharma R, Taran R, Trivedi S, Nabar S, Surekha S, Kumar S, Sawaimoon SK, Raina S, Narasimha S, Advani S, Ghouse SM, Muddu VK, Maniar V, Venkat V, Murthy V. Expert survey on management of prostate cancer in India: Real-world insights into practice patterns. Indian J Cancer. 2022 Mar;59(Supplement):S19-S45. doi: 10.4103/ijc.ijc_1145_21. PMID: 35343189.

Jeba J, Backianathan S, Ishitha G, Singh A. Oral and gastrointestinal symptomatic metastases as initial presentation of lung cancer. BMJ Case Rep. 2016 Nov 18;2016:bcr2016217539. doi: 10.1136/bcr-2016-217539. PMID: 27864300; PMCID: PMC5129147. Link

Chandramohan A, Siddiqi UM, Mittal R, Eapen A, Jesudason MR, Ram TS, Singh A, Masih D. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020 Feb 25;7:100223. doi: 10.1016/j.ejro.2020.100223. PMID: 32140502; PMCID: PMC7044654.

Chandramohan A, Siddiqi UM, Mittal R, Eapen A, Jesudason MR, Ram TS, Singh A, Masih D. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open. 2020 Feb 25;7:100223. doi: 10.1016/j.ejro.2020.100223. PMID: 32140502; PMCID: PMC7044654. Link

Joel A, Mathew N, Andugala SS, Daniel S, Gnanamuthu BR, John AO, Georgy JT, Chacko RT, Irodi A, Yadav B, John S, Singh A. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting. Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. PMID: 33777179; PMCID: PMC7987494. Link

Joel A, Georgy JT, Thumaty DB, John AO, Chacko RT, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Jacob PM, Sebastian P, Backianathan S, Singh A. Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India. Ecancermedicalscience. 2021 Mar 19;15:1207. doi: 10.3332/ecancer.2021.1207. PMID: 33912232; PMCID: PMC8057782.

Bakshi G, Tongaonkar H, Addla S, Menon S, Pradhan A, Kumar A, Bapat A, Gore A, Joshi A, Raja A, Bradoo A, Ramesh A, Kumar A, Agrawal A, Ambekar A, Joshi A, Singh A, Singh BP, Dabkara D, Khadakban D, Gautam G, Prakash G, Pahwa HS, Goel HK, Kulkarni J, Mishra JJ, Patel K, Pal M, Chibber PJ, Tiwari P, Naik R, Raghunath SK, Krishnatry R, Shimpi R, Sharma R, Taran R, Trivedi S, Nabar S, Surekha S, Kumar S, Sawaimoon SK, Raina S, Narasimha S, Advani S, Ghouse SM, Muddu VK, Maniar V, Venkat V, Murthy V. Expert survey on management of prostate cancer in India: Real-world insights into practice patterns. Indian J Cancer. 2022 Mar;59(Supplement):S19-S45. doi: 10.4103/ijc.ijc_1145_21. PMID: 35343189.

Sirohi B, Singh A, Dawood S, Shrikhande SV. Advances in chemotherapy for pancreatic cancer. Indian J Surg Oncol. 2015 Mar;6(1):47-56. doi: 10.1007/s13193-014-0371-y. Epub 2015 Jan 13. PMID: 25937764; PMCID: PMC4412866. Link

Jacob J, Mathew SK, Chacko RT, Aruldhas BW, Singh A, Prabha R, Mathew BS. Systemic exposure to 5-fluorouracil and its metabolite, 5,6-dihydrofluorouracil, and development of a limited sampling strategy for therapeutic drug management of 5-fluorouracil in patients with gastrointestinal malignancy. Br J Clin Pharmacol. 2021 Mar;87(3):937-945. doi: 10.1111/bcp.14444. Epub 2020 Jul 26. PMID: 32592630.

Gupta N, Nehra P, Chauhan AS, Mehra N, Singh A, Krishnamurthy MN, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Kataki AC, Dixit J, Gupta S, Kumar L, Prinja S. Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis. JCO Glob Oncol. 2022 Mar;8:e2100355. doi: 10.1200/GO.21.00355. PMID: 35286136; PMCID: PMC8932481.

Alka D, Abraham P, Ashish S, Anitha T, Vinotha T, Rachel CG, Ajit S. Primary peritoneal carcinoma and ovarian carcinoma - a ten-year comparative analysis. Klin Onkol. 2022 Winter;35(1):63-71. English. doi: 10.48095/ccko202263. PMID: 35236083.

Gupta N, Nehra P, Chauhan AS, Mehra N, Singh A, Krishnamurthy MN, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Kataki AC, Dixit J, Gupta S, Kumar L, Prinja S. Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India-A Model-Based Economic Analysis. JCO Glob Oncol. 2022 Mar;8:e2100355. doi: 10.1200/GO.21.00355. PMID: 35286136; PMCID: PMC8932481.

Sharma P, Georgy JT, Andrews AG, John AO, Joel A, Chacko RT, Premkumar PS, Singh A. Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome. Support Care Cancer. 2022 Mar 21:1–8. doi: 10.1007/s00520-022-06970-2. Epub ahead of print. PMID: 35314996; PMCID: PMC8937495.

Gupta D, Singh A, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S. Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO Glob Oncol. 2023 Feb;9:e2200246. doi: 10.1200/GO.22.00246. PMID: 36795991; PMCID: PMC10166401.

Agrawal, M., Konduru, V., Riju, J., Singh, A., Joel, A., Karuppusami, R. and Tirkey, A. J. Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center South Asian Journal of Cancer; 2023, 01:1-92, e1 Link

Georgy JT, Singh A, John AO, Joel A, Andrews AG, Thumaty DB, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Backianathan S, Chacko RT. Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy. Klin Onkol. 2021 Winter;34(1):49-55. English. doi: 10.48095/ccko202149. PMID: 33657819.

Gupta D, Singh A, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S. Cost-Effectiveness of the First Line Treatment Options For Metastatic Renal Cell Carcinoma in India. JCO Glob Oncol. 2023 Feb;9:e2200246. doi: 10.1200/GO.22.00246. PMID: 36795991; PMCID: PMC10166401. Link

Nehra P, Chauhan AS, Malhotra P, Kumar L, Singh A, Gupta N, Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S. Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India. Lancet Reg Health Southeast Asia. 2023 May 2;13:100201. doi: 10.1016/j.lansea.2023.100201. PMID: 37383548; PMCID: PMC10305972. Link

Gupta N, Gupta D, Dixit J, Mehra N, Singh A, Krishnamurthy MN, Jyani G, Rajsekhar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S. Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. Appl Health Econ Health Policy. 2022 May 10. doi: 10.1007/s40258-022-00731-2. Epub ahead of print. PMID: 35534752.

Alka D, Abraham P, Ashish S, Anitha T, Vinotha T, Rachel CG, Ajit S. Primary peritoneal carcinoma and ovarian carcinoma - a ten-year comparative analysis. Klin Onkol. 2022 Winter;35(1):63-71. English. doi: 10.48095/ccko202263. PMID: 35236083.

Joel A, Mathew N, Andugala SS, Daniel S, Gnanamuthu BR, John AO, Georgy JT, Chacko RT, Irodi A, Yadav B, John S, Singh A. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting. Ecancermedicalscience. 2021 Feb 11;15:1186. doi: 10.3332/ecancer.2021.1186. PMID: 33777179; PMCID: PMC7987494. Link

Singh A, Thomas Georgy J, Dhananjayan S, Sigamani E, Oommen John A, Joel A, Chandramohan J, Abarna R, Rebekah G, Backianathan S, Thomas Abraham D, Jacob Paul M, Titus Chacko R, Therese Manipadam M, Pai R. Comparative Analysis of Mutational Patterns in Triple Negative Breast Cancer Before and after Neoadjuvant Chemotherapy in Patients with Residual Disease. Gene. 2023 Nov 9:147980. doi: 10.1016/j.gene.2023.147980. Epub ahead of print. PMID: 37951371.

Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, John R, Singh A, Ram TS, Jesudason MR, Masih D, Karuppusami R. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2021 Dec 25. doi: 10.1111/codi.16032. Epub ahead of print. PMID: 34954863.

Punneshetty S, Sebastian A, Thomas V, Daniel S, Briskala P, Singh A, Thomas A. Malignant metastatic steroid cell tumor NOS: A rare presentation of a subtype of sex cord stromal tumor. Gynecol Oncol Rep. 2023 Mar 29;46:101169. doi: 10.1016/j.gore.2023.101169. PMID: 37082522; PMCID: PMC10111942.

Kuriakose J, Sundararaj JJ, Celine T, Isaac B, Mane M, Singh A, Sasidharan B. Osimertinib-induced radiation recall pneumonitis. BMJ Support Palliat Care. 2023 Apr 28:spcare-2023-004291. doi: 10.1136/spcare-2023-004291. Epub ahead of print. PMID: 37116943.

Alexander V, Rasalam JE, Kumar S, Daniel D, Nair SC, Subramani K, Chacko B, James EJ, David VG, Varughese S, Patel L, Jayalakshmi VT, Singh KA, Kumar S, Zachariah U, Goel A, Eapen CE. Transfusion-related lung complications are uncommon in non-ventilated liver failure patients undergoing low-volume plasma exchange. Indian J Gastroenterol. 2023 Aug 12. doi: 10.1007/s12664-023-01429-6. Epub ahead of print. PMID: 37572266. Link

Thumaty DB, Chacko RT, John AO, Joel A, Georgy JT, Jacob M, Samarasam I, Masih D, Isaiah R, Jeyaseelan V, Singh A. Docetaxel, Oxaliplatin and Capecitabine (TEX) triplet regimen as adjuvant chemotherapy in resected gastric adenocarcinoma. Ecancermedicalscience. 2021 Sep 21;15:1292. doi: 10.3332/ecancer.2021.1292. PMID: 34824615; PMCID: PMC8580596.

Prinja S, Dixit J, Gupta N, Mehra N, Singh A, Krishnamurthy MN, Gupta D, Rajsekar K, Kalaiyarasi JP, Roy PS, Malik PS, Mathew A, Pandey A, Malhotra P, Gupta S, Kumar L, Kataki A, Singh G. Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol. BMJ Open. 2021 Jul 29;11(7):e048513. doi: 10.1136/bmjopen-2020-048513. PMID: 34326050; PMCID: PMC8323373.

Singh A, Chatterjee P, Pai MC, Chacko RT. Gastrointestinal stromal tumours: a clinico-radiologic review from a single centre in South India. J Med Imaging Radiat Oncol. 2009 Dec;53(6):522-9. doi: 10.1111/j.1754-9485.2009.02118.x. PMID: 20002283.

Das A, Surendran S, Mathew M, Irodi A, Singh A, Joel A, Yacob M, Isiah R, Samarasam I, John S, Pavamani S, Sasidharan BK. Patterns of Recurrence in Locally Advanced Resectable Oesophageal Carcinoma: Retrospective Review from a Tertiary Cancer Centre in South India. J Gastrointest Cancer. 2021 Jun;52(2):711-718. doi: 10.1007/s12029-020-00464-2. PMID: 32720121.

Sharma P, Georgy JT, Andrews AG, John AO, Joel A, Chacko RT, Premkumar PS, Singh A. Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome. Support Care Cancer. 2022 Jun;30(6):5519-5526. doi: 10.1007/s00520-022-06970-2. Epub 2022 Mar 21. PMID: 35314996; PMCID: PMC8937495.

Singh A, Chatterjee P, Pai MC, Chacko RT. Multicystic peritoneal mesothelioma: not always a benign disease. Singapore Med J. 2013 Apr;54(4):e76-8. doi: 10.11622/smedj.2013085. PMID: 23624458.

Jose N, Joel A, Selvakumar RJ, Ramireddy J, John AO, Georgy JT, Singh A, Ram TS. Diagnosis and management of 5-fluorouracil (5-FU)-induced acute leukoencephalopathy: lessons learnt from a single-Centre case series. J Egypt Natl Canc Inst. 2022 May 23;34(1):22. doi: 10.1186/s43046-022-00117-4. PMID: 35599280. Link

Telugu RB, Kodiatte TA, Sakthi D, Isaiah R, Singh A, Gnanamuthu BR, Backianathan S. Primary pulmonary synovial sarcoma: A clinicopathological study of 22 cases. Malays J Pathol. 2022 Aug;44(2):215-224. PMID: 36043584. Link

Barnabas R, Singh A, Paul MJ, Paul TV. Uncommon cause of hypercalcaemia in metastatic breast carcinoma. BMJ Case Rep. 2018 Feb 22;2018:bcr2017223757. doi: 10.1136/bcr-2017-223757. PMID: 29472426; PMCID: PMC5847953. Link

John AO, Singh A, Bala D, Joel A, Georgy JT, Jesudasan MR, Mittal R, Ram TS, Reddy JR, Murthy A, Chandramohan A, Eapen A, Masih D, Ramnath N, Dobrosotskaya I, Yadav B, Chacko RT. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers. J Gastrointest Cancer. 2023 Jul 21. doi: 10.1007/s12029-023-00941-4. Epub ahead of print. PMID: 37479897.

Joel A, Singh A, Hepzibah J, Devasia A, Kumar S, Gnanamuthu BR, Chandramohan A, George AJP, John NT, Yadav B, John AO, Georgy JT, John S, Chacko RT. End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention? South Asian J Cancer. 2022 Aug 22;11(4):315-321. doi: 10.1055/s-0041-1735480. PMID: 36756102; PMCID: PMC9902077.

Sivamani P, Eriyat V, Mathew SK, Singh A, Aaron R, Chacko RT, Joel A, Prabha R, Mathew BS. Identification of DPYD variants and estimation of uracil and dihydrouracil in a healthy Indian population. Per Med. 2023 Jan;20(1):39-53. doi: 10.2217/pme-2022-0042. Epub 2022 Nov 23. PMID: 36416570.

Patra A, Lakhani A, Augustine A, Mohapatra P, Eapen A, Singh A, Masih D, Ram TS, Jesudason MR, Mittal R, Chandramohan A. Predicting Positive Radial Margin on Restaging MRI of Patients with Low Rectal Cancer: Can We Do Better? Indian J Radiol Imaging. 2023 Sep 16;34(1):85-94. doi: 10.1055/s-0043-1774300. PMID: 38106864; PMCID: PMC10723970.

Mathew N, Joel A, Andrews AG, John AO, Singh A. CDK 4/6 inhibitor induced lung injury: a case report and review of literature. Ecancermedicalscience. 2021 Jun 7;15:1245. doi: 10.3332/ecancer.2021.1245. PMID: 34267801; PMCID: PMC8241445.

Thomas Z, Jambunathan P, Jibi A, John AO, Singh A. Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region. BMJ Case Rep. 2023 Nov 3;16(11):e255021. doi: 10.1136/bcr-2023-255021. PMID: 37923331; PMCID: PMC10626912.

Singh A, Georgy JT, Joel A, Thumaty DB, John AO, Ramnath N, George TK, Sharma P, Patole S, Rebekah G, Sigamani E, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Sebastian P, Backianathan S, Chacko RT. Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer. Cancer Invest. 2023 Oct;41(9):789-802. doi: 10.1080/07357907.2023.2278048. Epub 2023 Nov 17. PMID: 37909664.

Kuriakose J, Sundararaj JJ, Celine T, Isaac B, Mane M, Singh A, Sasidharan B. Osimertinib-induced radiation recall pneumonitis. BMJ Support Palliat Care. 2023 Apr 28:spcare-2023-004291. doi: 10.1136/spcare-2023-004291. Epub ahead of print. PMID: 37116943.

Dixit J, Malhotra P, Mehra N, Mathew A, Kumar L, Singh A, Gupta N, Krishnamurthy MN, Roy PS, Kataki AC, Gupta S, Prinja S. Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India. Appl Health Econ Health Policy. 2024 Mar 7. doi: 10.1007/s40258-024-00877-1. Epub ahead of print. PMID: 38448720. Link

Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S. Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Front Public Health. 2023 Jun 19;11:1065737. doi: 10.3389/fpubh.2023.1065737. PMID: 37404274; PMCID: PMC10316647. Link